1 interaction related to gymnema
Gymnema is sold to lower blood sugar, so it may add to glipizide's effect and raise the chance of lows. The main human evidence is a 1990 study of 22 people with type 2 diabetes on oral diabetes drugs (the abstract does not name the drugs or describe a placebo group) who took a gymnema leaf extract for 18 to 20 months: blood sugar and glycated hemoglobin fell, their usual drug doses could be lowered, and 5 were able to stop their drug. A rat study with glimepiride, another sulfonylurea, found extra glucose lowering without a major change in drug levels.